Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Beam Therapeutics Inc shares valued at $104,122 were sold by Bellon Christine on Apr 01 ’25. At $18.35 per share, Bellon Christine sold 5,674 shares. The insider’s holdings dropped to 117,294 shares worth approximately $2.05 million following the completion of this transaction.
Also, Evans John M. sold 30,663 shares, netting a total of over 562,684 in proceeds. Following the sale of shares at $18.35 each, the insider now holds 986,249 shares.
Before that, Ciaramella Giuseppe had sold 7,434 shares from its account. In a trade valued at $136,418, the President traded Beam Therapeutics Inc shares for $18.35 each. Upon closing the transaction, the insider’s holdings decreased to 7,434 shares, worth approximately $3.32 million.
As published in a research note from BofA Securities on March 28, 2025, Beam Therapeutics Inc [BEAM] has been rated up from a Neutral to a Buy and the price target has been revised to $42. Analysts at Scotiabank upgraded the stock from ‘”a Sector perform”‘ to ‘”a Sector outperform”‘ outlook in a report released in early March. As of January 29, 2025, Cantor Fitzgerald has increased its “Neutral” rating to a “an Overweight” for BEAM. Earlier on November 06, 2024, Leerink Partners upgraded its rating. Their new recommendation was “an Outperform” for BEAM stock which previously was a “a Market perform”.
Analyzing BEAM Stock Performance
On last trading session,, Beam Therapeutics Inc [NASDAQ: BEAM] plunged -2.52% to $17.44. The stock’s lowest price that day was $17.0, but it reached a high of $17.7398 in the same session. During the last five days, there has been a surge of approximately 2.59%. Over the course of the year, Beam Therapeutics Inc shares have dropped approximately -29.68%.
Support And Resistance Levels for Beam Therapeutics Inc (BEAM)
RSI (Relative Strength Index) is 48.38 on the 14-day chart, showing neutral technical sentiment.
Is Beam Therapeutics Inc subject to short interest?
Stocks of Beam Therapeutics Inc saw a sharp rise in short interest on 2025-05-30 jumping by 1.9 million shares to 21.16 million. Data from Yahoo Finance shows that the short interest on 2025-04-30 was 19.26 million shares. A jump of 8.97% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 10.76 of the overall float, the days-to-cover ratio (short ratio) jumped to 10.76.
